Anesthesia: Essays and Researches  Login  | Users Online: 353 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Home | About us | Editorial board | Ahead of print | Search | Current Issue | Archives | Submit article | Instructions | Copyright form | Subscribe | Advertise | Contacts

Table of Contents  
Year : 2017  |  Volume : 11  |  Issue : 3  |  Page : 630-635  

Periprocedural management of vein of galen aneurysmal malformation patients: An 11-year experience

Department of Anaesthesiology, Neuroanesthesia Division, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India

Date of Web Publication07-Apr-2017

Correspondence Address:
Ajay Prasad Hrishi
Department of Anaesthesiology, Neuroanesthesia Division, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/aer.AER_252_16

Rights and Permissions

Context: The vein of Galen aneurysmal malformation (VGAM) is a rare arteriovenous malformation where a dilated median prosencephalic vein provides a low-resistance conduit for intracerebral blood flow resulting in high-output cardiac failure, severe pulmonary hypertension, with or without central nervous system symptoms secondary to hydrocephalus, in the neonatal and pediatric population. Aim: This study aims to analysis of the anesthetic management of this unique subset of patients with VGAM. Settings and Design: This was a retrospective analysis of case series of VGAM patients admitted between January 2005 and June 2016 in our Institute. Subjects and Methods: Case records of VGAM patients were reviewed for the anesthetic technique and medications administered. The incidence of intra-and post-procedural complications and their management and outcomes were analyzed. Statistical Analysis: Parametric data were expressed as mean and standard deviation. Descriptive statistics was used for describing associated pathologies, drugs and monitors used during the procedure, incidence of any adverse events, and the treatment protocol. Results: Twenty-one patients underwent treatment for the VGAM. There were a total of forty anesthetics administered for embolization, diagnostic angiography, and magnetic resonance imaging. Eighty-five percent had increased head circumference, 40% had associated focal neurological deficits, and 15% had seizures as presenting symptoms. Cardiac anomalies were seen in 41% of the patients, and difficult airway was anticipated in 38% of the patients. The majority of the patients had inhalational induction (62.2%) and inhalation maintenance (84.4%) of anesthesia. Intraprocedural adverse events were noted in 43% and postprocedure complications in 38% of the patients. Conclusion: Anesthetic management for embolization of VGAM with a combination of opioids and inhalational agents helps in minimizing the incidence of intraprocedural adverse events and provides a better hemodynamic profile.

Keywords: Anesthetic implications, interventional neuroradiology, vein of Galen aneurysmal malformation

How to cite this article:
Hrishi AP, Lionel KR. Periprocedural management of vein of galen aneurysmal malformation patients: An 11-year experience. Anesth Essays Res 2017;11:630-5

How to cite this URL:
Hrishi AP, Lionel KR. Periprocedural management of vein of galen aneurysmal malformation patients: An 11-year experience. Anesth Essays Res [serial online] 2017 [cited 2020 Nov 27];11:630-5. Available from:

   Introduction Top

The Vein of Galen Aneurysmal Malformation (VGAM) is a rare (1/25,000 deliveries) arteriovenous malformation that presents in the pediatric and neonatal age group.[1],[2] Here, the dilated median prosencephalic vein provides a low-resistance conduit for intracerebral blood flow, ensuing in high-output cardiac failure, and severe pulmonary hypertension with or without central nervous system symptoms secondary to hydrocephalus [Figure 1]. Chronic progressive hydrocephalus attributed to absorptive malfunction secondary to high intracerebral venous pressure results in macrocephaly with cerebral atrophy [Figure 2] and the child not attaining developmental milestones appropriate for age.[3],[4],[5] The VGAM serves as a large intracerebral shunt causing hypoperfusion of the normal brain tissue thus exacerbating neurological injury. This complex pathophysiology also fosters a systemic hypoperfusion which may present as renal and hepatic dysfunction.
Figure 1: Vein of Galen aneurysmal dilatation: Carotid angiogram in a patient with vein of Galen aneurysmal dilatation showing an arteriovenous malformation draining into a dilated venous sac

Click here to view
Figure 2: Computed tomography scan in a 9-month-old child with vein of Galen malformation. Plain axial computed tomography scan of the brain showing dilated ventricles due to hydrocephalus and gross cerebral atrophy

Click here to view

Neuroradiological intervention with transcatheter embolism is the procedure of choice to occlude the VGAM owing to the fact that it is less invasive and has a higher survival rate than open neurosurgical procedures.[6],[7],[8] Anesthetic and critical care management of these patients prove to be a challenge due to the risk of periprocedural complications such as congestive cardiac failure (CCF) and cerebral infarction. Furthermore, the airway management of these neonates and infants with macrocephaly secondary to the VGAM and hydrocephalus presents a unique challenge.

A PubMed search regarding VGAM and its management yielded isolated case reports. This is again attributed to the rarity of this complex pathology and presentation of patients with VGAM. An analysis was done to identify the optimal anesthetic and intensive care management of this group of patients as till date there are no set protocols or guidelines referring to the management of the same. This is again attributed due to the rare incidence of VGAM making clinical analysis of the optimal anesthetic and intensive care management a difficult task. We hereby report an 11-year retrospective analysis of the periprocedural management of VGAM patients, which, to the best of our knowledge is the largest case series from a tertiary care neurological center.

   Subjects and Methods Top

Since prospective studies are not feasible in the setting of rare pathologies such as VGAM, we decided to retrospectively analyze a case series over the past one decade. We present the data as a descriptive essay of a large case series identifying the optimal clinical management based on our reliable databank. We also illustrate the difficulties commonly encountered in managing these cases and their management at our tertiary care center. After approval from the Institutional Ethics Committee, a retrospective analysis of case records of VGAM patients from January 2005 to June 2016 was performed. Data were collected using a data collection pro forma, and the records were screened for information regarding eight nonvariable entities: (i) Patient demographics, (ii) presence or absence of associated cardiopulmonary involvement, (iii) presence of comorbid illnesses, (iv) airway assessment, (v) baseline hemodynamic parameters, (vi) intraprocedure adverse events, (vii) management of intraprocedure adverse events, and (viii) postprocedural complications. Any case records which did not convey data regarding all these eight clinical entities were deemed incomplete and were not included in the analysis. We followed this method to avoid clinical bias and other confounding variables. The primary parameter assessed was the periprocedural management, including the anesthetic technique used during the neuroradiological intervention for the VGAM. The incidence of intra- and post-procedure complications, their management, and the outcome were the secondary parameters investigated.

We defined an anticipated difficult airway by the following criteria: (i) Previous history of difficult bag-mask ventilation or intubation, (ii) examination revealing a large head (>2.5 standard deviation [SD] of expected), and (iii) Mallampati score of ≥3. Cardiorespiratory adverse events were defined as episodes of hypertension (>20% increase from baseline for >5 min), hypotension (>20% decrease from baseline for >5 min), tachycardia (>20% change from baseline for >5 min), and bradycardia (>20% change from baseline or heart rate <60/min for >5 min). Cardiac arrhythmias and episodes of desaturation (pulse oximetry [SpO2] >5% drop or <92%) were the other adverse events looked for.

Statistical analysis

Stata 11 software (StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP) was used for analysis. Parametric data were expressed as mean and SD. Descriptive statistics was used for describing associated pathologies, drugs, and monitors used during the procedure, incidence of any adverse events, and the treatment protocol. P < 0.05 was considered statistically significant.

   Results Top

A total of 25 patients presented with the diagnosis of VGAM to the hospital during the period between January 2005 and June 2016. All of them underwent neuroradiological interventions for VGAM. Four patients were excluded from the analysis as their records it did not fulfill data collection criteria. In the 21 patients whose records were analyzed the mean age was 3.8 years and ranged between 3 months and 16 years, with a male to female ratio of 13:8.

Of these 21, 85% had increased head circumference (>2 SD for the age), 40% had associated focal neurological deficits, and 15% had seizures as the presenting feature. All patients had hydrocephalus diagnosed at the initial imaging, of which 67.6% were moderate to severe in nature. Cardiac anomalies were the most commonly associated congenital malformations as seen in 41% of the patients, out of which 75% had atrial septal defects (ASD), 12.5% ventricular septal defects (VSD), and 12.5% patent ductus arteriosus (PDA). Two (9.5%) of our patients presented with neonatal CCF and severe pulmonary arterial hypertension [Figure 3] both of whom responded to management with periprocedural sildenafil and milrinone. In our study population, 32% were found to be underweight (<2 SD of the weight for age) and 18% were anemic with one subject requiring preprocedural blood transfusion due to a low hemoglobin level of 5.7 g/dl.
Figure 3: Plain radiograph of the chest showing cardiomegaly (right ventricular hypertrophy) and features of pulmonary hypertension and hepatomegaly

Click here to view

The neuroradiologic procedure carried out was transcatheter arterial embolization in all patients, and the duration of intervention ranged between 75 and 780 min with a mean duration of 340 min. A total of 34 embolization procedures were carried out in these 21 patients as 71.4% of the patients required multiple episodes of embolization during the study period owing to the fact that total embolization of a large shunt in a single sitting can result in rapid deterioration of both cardiac and neurological status due to the sudden removal of a high flow shunt from the circulation. The embolization material used was N-butyl cyanoacrylate (n = 20), or ethylene vinyl alcohol copolymer (n = 14). There were a total of forty anesthetic procedures carried out, of which 85% of the anesthetics were for embolization, 5% were for follow-up check angiography, and 10% were for diagnostic magnetic resonance imaging (MRI).

Preprocedural assessment of the airway revealed that 38% had an anticipated difficult airway, of whom 40% had a Cormack and Lehane (CL) Grading of 1 or 2 and 60% had a CL Grade 3. Out of the total anticipated difficult airways in the study population, 60% were intubated at the first attempt and 40% required 2 or more attempts at intubation aided by airway gadgets (bougie/video laryngoscope).

Among the anesthetics administered to these patients with VGAM, 62.2% had an inhalational induction with sevoflurane. In patients who had an intravenous (IV) induction, 82.3% received injection propofol (1–2 mg/kg), and the rest received injection thiopentone (4–7 mg/kg). Both groups were given injection fentanyl 1–2 μg/kg and injection vecuronium 0.1 mg/kg to facilitate endotracheal cannulation. Mechanical ventilation was done with pressure control mode targeting a tidal volume of 8–10 ml/kg. Anesthesia was maintained in 84.4% of the anesthetics with a combination of sevoflurane up to 0.8 minimum alveolar concentration (MAC), oxygen and air mixture (50:50) and an infusion of injection fentanyl (1–2 μg/kg/h), while the rest received total IV anesthesia (TIVA) with injection propofol (75–100 μg/kg/min) and injection fentanyl (1–2 μg/kg/h). The anesthetic management for diagnostic angiography and MRI was done under sedation with injection propofol (25–75 μg/kg/min) with supplemental oxygen up to 60% FiO2, through face mask. In addition to the routine preinduction monitors of electrocardiograph, SpO2 and noninvasive blood pressure, all patients who underwent embolization had invasive arterial blood pressure (ABP), central venous pressure (CVP), and temperature monitoring as well.

The analysis of intraprocedural adverse events revealed an overall incidence of 43% with episodes of hypotension in 33.3%, hypertension in 13.3%, tachycardia in 11%, and bradycardia in 6.6% of the patients. Postinduction hypotension was higher with IV induction (20%) as compared to the inhalational method (13%), but this was not statistically significant (P > 0.05). About 90% of the hypotensive episodes were managed successfully with IV fluid boluses and injection mephentermine 3 mg boluses. Two infants with preprocedural CCF on treatment with tablet digoxin and injection furosemide responded well to an injection milrinone infusion (0.35–0.75 μg/kg/min). Intraprocedural tachycardia and hypertensive episodes occurred more frequently in patients maintained on inhalational anesthetics (68.9%) when compared to the TIVA group, and this was statistically significant (P < 0.05). Tachycardia was managed successfully in 66.6% of the patients with fentanyl boluses (1–2 μg/kg) and the rest responded to an additional increase in the depth of anesthesia up to 1.0 MAC. In patients who developed hypertensive episodes, 50% settled after fentanyl boluses (1–2 μg/kg) while the other half required injection sodium nitroprusside (SNP) infusion (2–5 mcg/kg/min). Bradycardia was noticed during the deposition of the embolizing material in two patients receiving TIVA compared to one patient in the inhalational group. One of the patients with bradycardia in the TIVA group required treatment with atropine while the others were transient and recovered spontaneously. Other adverse intraprocedural adverse events such as desaturation, arrhythmias, or cardiac arrest did not occur. No adverse events were noted during diagnostic angiography or during MRI procedures.

Postprocedure, all patients were shifted to the interventional radiology Intensive Care Unit for monitoring for a minimum period of 48 h. Postprocedural complications were seen in 38% of patients who underwent embolization. Three patients had transient low sensorium; one had persistent seizures in whom the postprocedural imaging revealed bilateral thalamic infarcts and two other patients had worsening of hydrocephalus requiring placement of external ventricular drains. Another patient presented with an acute drop in Glasgow Coma Scale, 6 h postprocedure due to accelerated thrombosis of the embolized VGAM requiring emergent intubation. One patient who was intubated for worsening of CCF later required a tracheostomy since the cardiac failure was worsened by severe respiratory distress secondary to sepsis. This patient also had a cardiac arrest in the immediate postprocedural period requiring cardiopulmonary resuscitation which was successful. None of the patients presenting for diagnostic procedures had complications.

Sedation for postprocedural mechanical ventilation was instituted with morphine (0.1 mg/kg/h) and midazolam (0.05–0.1 mg/kg/h) infusion in 87.5% of patients, while the rest received injection dexmedetomidine (0.2–0.5 mcg/kg/h) infusion. Pressure control ventilation was used in all patients who required postprocedural ventilation.

   Discussion Top

Although this unique condition falls under the broad classification of intracerebral arteriovenous malformations, the anesthetic implications of VGAM vary drastically due to the associated multiple systemic complications and early presentation in life. Our review revealed that majority of our patients presented at a higher average age with neurological symptomatology, such as increased head circumference, neurological deficits, and seizures, in contrast to their counterparts in developed countries where children usually presented in the neonatal period with cardiac symptoms.[9],[10] Hence, our management was tailored to address the same, with goals to ensure no further deterioration in the neurological status by avoiding any further raise in intracranial pressure (ICP), maintenance of normal cerebral perfusion pressure (CPP), and cerebral oxygenation. Our anesthetics were titrated keeping in mind the cerebral steal circulation along with the coexistence of cardiopulmonary pathologies.

The most commonly associated congenital anomalies in our population were structural heart pathologies consisting of ASD, VSD, and PDA with two patients having an Eisenmenger's complex. Both these patients responded well to periprocedural sildenafil and milrinone as our goals were to increase the cardiac output and to keep the systemic vascular resistance (SVR) and peripheral vascular resistance (PVR) low. These patients further sustain a cardiac insult attributed to the fact that blood flow through the VGAM during diastole, creates a steal phenomenon causing a reduction in diastolic pressure which may lead to myocardial ischemia secondary to reduced coronary blood flow.[9],[10]

The majority of these patients fail to thrive due to poor feed tolerance and easy fatigability as seen in children with cardiac failure. The associated nausea and vomiting attributed to the hydrocephalus compounds this, causing them to be malnourished and anemic. Anemia further worsens the existing hyperdynamic circulation and also reduces oxygen delivery to the brain. Thus, a higher PaO2 (100–250 mmHg) is required to ensure adequate brain and peripheral tissue oxygenation, and a higher transfusion trigger (10 g/dl) is preferred as well.[11],[12] Malnourishment leads to hypoproteinemia aggravating the circulatory failure, tissue edema, and altered pharmacokinetics.[13],[14]

All patients undergoing embolization had invasive monitors which included ABP and CVP. Invasive hemodynamic monitoring in these cases proves to be pivotal due to associated coronary heart disease (CHD) and also in optimizing the CPP. The large shunt through the VGAM, compromises blood flow to the peripheries, resulting in collapsed veins and barely felt arterial pulses which makes venous and arterial cannulation a difficult task. Central venous cannulation particularly of the internal jugular vein is a challenge as the intracranial shunt makes even the venous column pulsatile. Furthermore, venous blood appears bright to the naked eye due to low central oxygen extraction which is reflected as a high partial pressure of oxygen in the blood gas sampled from the venous line. Thus, central venous cannulation must be carried out under ultrasound guidance. Longer cables for all monitors as well as adequate length of breathing circuits must be ensured.

More than a quarter (38%) of our patients had an anticipated difficult airway, of which 40% required 2 or more attempts to intubate the trachea. This difficult airway scenario is mainly due to the presence of a larger head compared to normal subjects of the same age and the challenging airway anatomy of the neonate and infant. This can be overcome by stabilizing the head in a head ring and using a small pillow/roll under the back or shoulders to achieve a proper sniffing position, further aided by airway gadgets such as a gum elastic bougie or video laryngoscope. A quick airway establishment is important in this population as they tend to desaturate faster due to the associated congenital heart disease.[15],[16]

In our center, the preferred anesthetic technique for induction was inhalational, using sevoflurane and majority of our patients were maintained with a combination of sevoflurane and fentanyl infusion and the remaining were maintained with propofol and fentanyl TIVA. Postinduction hypotension was higher in patients who underwent IV induction, and though this was not statistically significant (P - 0.12), it was probably attributed to the cardiac depressive effect of thiopentone and propofol.[17],[18] The conventional ketamine induction which is advocated in patients with CHD cannot be utilized here due the risk of aggravating the ICP/seizures and thereby worsening the neurological status.[19] Thus, a titrated inhalational and opioid induction would be beneficial in this subset of patients. Maintenance with isoflurane or sevoflurane is optimal as it has minimal effect on the myocardial contractility or shunt fraction.[20] The increased incidence of tachycardia and hypertensive episodes in the inhalational group maybe due to the inadequate depth of anesthesia possibly due to the slow uptake of the inhalational agent attributed to the cardiac shunt and also to a low target site concentration due the intracranial shunt. These episodes were managed effectively by supplemental doses of opioids and by deepening the anesthetic plane. The hypertensive episodes refractory to this can be effectively management by short-acting vasodilators like SNP which being a nitric oxide donor, improves the pulmonary circulation as well as the cardiac output by reducing the SVR.[21],[22] Hypotensive episodes in these patients can be effectively managed with boluses of short-acting vasopressors like injection mephentermine or injection phenylephrine. Hypotension is commonly encountered due to intraarterial use of vasoactive agents like nimodipine, SNP, and milrinone by the neuroradiologists. Dislodgement of glue (N-butyl cyanoacrylate) during the neurointervention can present with pulmonary embolism-like features. Bradycardia is encountered during embolization of large intracranial shunts. This is attributed to the sudden transient raise in ICP caused by the occlusion of the low-resistance intracranial shunt.

Intraprocedure positioning of the macrocephaly child must be done with great care to prevent kinking of the neck vessels. We position our neonates and infants using a doughnut head pillow to accommodate the large head and a flat pillow below the trunk to avoid hyperflexion. Fluid management too proves to be a difficult task since urine output monitoring will not reflect the volume status, as these patients are on periprocedural diuretics and osmotic agents for the management of the raised ICP, thus warranting intraprocedural CVP monitoring and appropriate replacement with dextrose-free crystalloids.[23] Contrast-induced diuresis caused by hyperosmolar contrast agents and cold diuresis in the interventional radiology suite further aggravates the preexisting hypovolemia and dyselectrolytemia. Hypothermia, commonly encountered in the interventional suite increases the SVR and also delays drug metabolism. Hence, careful temperature monitoring and use of forced air warmers are mandatory.

Postprocedural complications were seen in 38% of patients which included development of new focal neurological deficits, seizures, worsening of hydrocephalus, and precipitation of CCF thus requiring the expertise of the anesthesiologist in securing the airway, mechanical ventilation, and hemodynamic resuscitation. During the postembolization phase, there is a drastic shift in the intracranial circulatory dynamics as occlusion of the low-resistance high-volume conduit results in cerebral hyperperfusion, cerebral edema, and venous infarcts. Other complications include intracranial hemorrhage, cerebral venous thrombosis, and worsening of the hydrocephalus. Hypertension needs to be avoided in the first 48 h after the procedure to prevent neurological hyperperfusion injury, and this is effectively achieved with an infusion of SNP.[9],[10] Exclusion of the low-resistance circuit from the circulation will increase the afterload, transiently worsening the cardiac status of these patients, who usually respond well to milrinone. Sedation in the postoperative period is best achieved with morphine which aids in improving the PVR, apart from providing excellent analgesia and sedation for mechanical ventilation. Pressure control mode of ventilation is preferred, due to the poor lung compliance secondary to pulmonary edema, which can be a common presentation during the postprocedural period.

The anesthetic management of diagnostic procedures inclusive of both angiography and MRI under IV sedation with propofol (25–75 mcg/kg/min) did not have any intra- and post-procedural adverse events. This is ascribed to the fact that there were no alterations in the circulatory dynamics.

This study, apart from representing a small population, due to the rarity of this condition also has the limitation that it does not represent patients who have undergone surgical management of the same. Anesthesia for surgical management will present an even more challenging situation to the anesthesiologist due to perioperative surgical stress, blood loss, dynamic homeostasis, and increased incidence of postoperative complications.[6],[7] A prospective study will be time-consuming and may not be clinically feasible because of the low incidence of cases of VGAM, thus making this large case series a valuable source of clinical information.

   Conclusion Top

VGAMs are a rare presentation, with a plethora of pathologies which include neurological deficits, associated congenital heart disease with or without cardiac failure and difficult airways. The goals of management are to avoid further neurological injury by maintaining normal CPP, cardiac stability, and providing a quiet field for successful VGAM embolization. Anesthetic management for embolization of VGAM with a combination of opioids and inhalational agents helps in minimizing the incidence of intraprocedural adverse events and also provides a better hemodynamic profile.


Dr. Jayadevan E.R., Associate professor, Imaging sciences and Intervention radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India, for his expert opinion and guidance.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Brunelle F. Arteriovenous malformation of the vein of Galen in children. Pediatr Radiol 1997;27:501-13.  Back to cited text no. 1
Gupta AK, Varma DR. Vein of Galen malformations: Review. Neurol India 2004;52:43-53.  Back to cited text no. 2
[PUBMED]  [Full text]  
Lasjaunias P, Garcia-Monaco R, Rodesch G, Ter Brugge K, Zerah M, Tardieu M, et al. Vein of Galen malformation. Endovascular management of 43 cases. Childs Nerv Syst 1991;7:360-7.  Back to cited text no. 3
Andeweg J. Intracranial venous pressures, hydrocephalus and effects of cerebrospinal fluid shunts. Childs Nerv Syst 1989;5:318-23.  Back to cited text no. 4
Ciricillo SF, Edwards MS, Schmidt KG, Hieshima GB, Silverman NH, Higashida RT, et al. Interventional neuroradiological management of vein of Galen malformations in the neonate. Neurosurgery 1990;27:22-7.  Back to cited text no. 5
McConnell ME, Aronin P, Vitek JJ. Congestive heart failure in neonates due to intracranial arteriovenous malformation: Endovascular treatment. Pediatr Cardiol 1993;14:102-6.  Back to cited text no. 6
Lasjaunias P, Rodesch G, Pruvost P, Laroche FG, Landrieu P. Treatment of vein of Galen aneurysmal malformation. J Neurosurg 1989;70:746-50.  Back to cited text no. 7
Lylyk P, Viñuela F, Dion JE, Duckwiler G, Guglielmi G, Peacock W, et al. Therapeutic alternatives for vein of Galen vascular malformations. J Neurosurg 1993;78:438-45.  Back to cited text no. 8
Chevret L, Durand P, Alvarez H, Lambert V, Caeymax L, Rodesch G, et al. Severe cardiac failure in newborns with VGAM. Prognosis significance of hemodynamic parameters in neonates presenting with severe heart failure owing to vein of Galen arteriovenous malformation. Intensive Care Med 2002;28:1126-30.  Back to cited text no. 9
Pellegrino PA, Milanesi O, Saia OS, Carollo C. Congestive heart failure secondary to cerebral arterio-venous fistula. Childs Nerv Syst 1987;3:141-4.  Back to cited text no. 10
Kumar MA. Red blood cell transfusion in the neurological ICU. Neurotherapeutics 2012;9:56-64.  Back to cited text no. 11
Ali Z, Hassan N, Syed S. Blood transfusion practices in neuroanaesthesia. Indian J Anaesth 2014;58:622-8.  Back to cited text no. 12
[PUBMED]  [Full text]  
DeVane CL. Clinical significance of drug binding, protein binding, and binding displacement drug interactions. Psychopharmacol Bull 2002;36:5-21.  Back to cited text no. 13
McElnay JC, D'Arcy PF. Protein binding displacement interactions and their clinical importance. Drugs 1983;25:495-513.  Back to cited text no. 14
Menghraj SJ. Anaesthetic considerations in children with congenital heart disease undergoing non-cardiac surgery. Indian J Anaesth 2012;56:491-5.  Back to cited text no. 15
Kaye AD, Stout TB, Padnos IW, Schwartz BG, Baluch AR, Fox CJ, et al. Left-to-right cardiac shunt: Perioperative anesthetic considerations. Middle East J Anaesthesiol 2012;21:793-806.  Back to cited text no. 16
Etsten B, Li TH. Hemodynamic changes during thiopental anesthesia in humans: Cardiac output, stroke volume, total peripheral resistance, and intrathoracic blood volume. J Clin Invest 1955;34:500-10.  Back to cited text no. 17
Mohindra R, Beebe DS, Belani KG. Anaesthetic management of patients with congenital heart disease presenting for non-cardiac surgery. Ann Card Anaesth 2002;5:15-24.  Back to cited text no. 18
[PUBMED]  [Full text]  
Shaprio HM, Wyte SR, Harris AB. Ketamine anaesthesia in patients with intracranial pathology. Br J Anaesth 1972;44:1200-4.  Back to cited text no. 19
Rivenes SM, Lewin MB, Stayer SA, Bent ST, Schoenig HM, McKenzie ED, et al. Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: An echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology 2001;94:223-9.  Back to cited text no. 20
López-López JG, Pérez-Vizcaíno F, Cogolludo AL, Ibarra M, Zaragozá-Arnáez F, Tamargo J. Nitric oxide- and nitric oxide donors-induced relaxation and its modulation by oxidative stress in piglet pulmonary arteries. Br J Pharmacol 2001;133:615-24.  Back to cited text no. 21
Adrie C, Ichinose F, Holzmann A, Keefer L, Hurford WE, Zapol WM. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J Appl Physiol 1998;84:435-41.  Back to cited text no. 22
Ali Z, Prabhakar H. Fluid management during neurosurgical procedures. J Neuroanaesth Crit Care 2016;3:35-40.  Back to cited text no. 23


  [Figure 1], [Figure 2], [Figure 3]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
   Subjects and Methods
    Article Figures

 Article Access Statistics
    PDF Downloaded128    
    Comments [Add]    

Recommend this journal